NewAmsterdam Pharma Co N.V.

Ownership Transactions Reported by 18 Insiders

Symbol
NAMS, NAMSW on Nasdaq
Industry
Pharmaceutical Preparations
Location
Gooimeer 2 35, Narrden, Netherlands

Insiders trading volume in the past year

NewAmsterdam Pharma Co N.V. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ForGrowth NAP B.V. 10%+ Owner $225M Jan 1, 2024
Bain Capital Life Sciences Investors, LLC 10%+ Owner $199M Dec 29, 2023
James Topper Director $146M +$181K +0.12% Mar 26, 2024
Michael H. Davidson Chief Executive Officer, Director $14M +$86.3K +0.62% Jun 20, 2024
Louis G. Lange Director $660K +$95K +16.8% Feb 13, 2024
Johannes Jacob Pieter Kastelein Chief Scientific Officer, Director $0 -$4.1M -100% Mar 26, 2024
John W. Smither Director Jan 1, 2024
Mayur Ian Somaiya Chief Financial Officer Jan 1, 2024
Hilde Johanna van der Kamp Director Jan 1, 2024
Douglas F. Kling Chief Operating Officer Jan 1, 2024
Louise Kooij Chief Accounting Officer Jan 1, 2024
Mark C. McKenna Director Jul 17, 2024
William Lewis Director Jan 4, 2024
Wouter Joustra Director Jul 16, 2024
Hugo Alexander Slootweg Director Dec 29, 2023
Nicholas Downing Director Dec 29, 2023
Juliette Berangere Audet Chief Business Officer Apr 1, 2024
William Jones Chief Commercial Officer Apr 25, 2024

Recent Insider Transactions by Companies or Individuals for NewAmsterdam Pharma Co N.V.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.